Preface | p. v |
Tables and figures | p. xi |
Bioequivalence Testing Rationale and Principles | p. 1 |
Regulatory Aspects of Bioequivalence Testing | p. 45 |
Pharmacokinetic and Pharmacodynamic Modeling | p. 61 |
Waiver of Bioavailability/Bioequivalence Studies | p. 69 |
Regulatory Review Process | p. 89 |
Statistical Evaluation of Bioequivalence Data | p. 119 |
Physicochemical Properties Affecting Bioequivalence | p. 163 |
Drug Delivery Factors | p. 197 |
Bioanalytical Method Validation | p. 237 |
Good Clinical Practice | p. 265 |
Good Laboratory Practices for Nonclinical Laboratory Studies | p. 295 |
Computer and Software Validation | p. 317 |
Bioequivalence Reports | p. 339 |
Glossary of Terms | p. 443 |
Bioequivalence Testing Literature | p. 461 |
Dissolution Testing Methods of Approved Drugs | p. 535 |
Index | p. 553 |
Table of Contents provided by Ingram. All Rights Reserved. |
The New copy of this book will include any supplemental materials advertised. Please check the title of the book to determine if it should include any access cards, study guides, lab manuals, CDs, etc.
The Used, Rental and eBook copies of this book are not guaranteed to include any supplemental materials. Typically, only the book itself is included. This is true even if the title states it includes any access cards, study guides, lab manuals, CDs, etc.